Table 2. Standardized difference between CASG and non-CASG participants in the full and propensity score matched cohort.
| Full Cohort | Propensity Score Matched Cohort | |||||
|---|---|---|---|---|---|---|
| CASG | CASG | |||||
| Yes (N = 6,760) | No (N = 123,178) | Standardized Difference | Yes (N = 6,648*) | No (N = 6,648*) | Standardized Difference | |
| Year of ART Initiation | ||||||
| 2004/2005 | 0% | 0% | 0.031 | 0% | 0% | -0.001 |
| 2006 | 3% | 1% | 0.135 | 3% | 3% | -0.029 |
| 2007 | 12% | 4% | 0.281 | 12% | 10% | 0.039 |
| 2008 | 14% | 5% | 0.315 | 14% | 13% | 0.025 |
| 2009 | 18% | 7% | 0.316 | 18% | 18% | 0.003 |
| 2010 | 21% | 10% | 0.287 | 20% | 21% | -0.002 |
| 2011 | 18% | 15% | 0.064 | 18% | 18% | -0.010 |
| 2012 | 13% | 27% | -0.356 | 13% | 15% | -0.040 |
| 2013/2014 | 2% | 30% | -0.814 | 2% | 2% | 0.012 |
| Sex | ||||||
| Male | 26% | 32% | -0.147 | 26% | 26% | -0.003 |
| Female | 74% | 68% | 0.147 | 74% | 74% | 0.003 |
| Education | ||||||
| None | 22% | 14% | 0.220 | 22% | 21% | 0.017 |
| Other | 1% | 1% | -0.030 | 1% | 0% | 0.005 |
| Primary | 62% | 62% | 0.013 | 62% | 63% | -0.012 |
| Secondary | 15% | 23% | -0.206 | 15% | 15% | 0.002 |
| University | 0% | 1% | -0.087 | 0% | 1% | -0.027 |
| WHO Stage | ||||||
| I | 28% | 40% | -0.259 | 28% | 28% | -0.006 |
| II | 28% | 25% | 0.061 | 27% | 28% | -0.011 |
| III | 38% | 30% | 0.178 | 39% | 38% | 0.004 |
| IV | 6% | 5% | 0.049 | 6% | 5% | 0.026 |
| Age (Mean) | 37.68 | 35.09 | 0.248 | 37.64 | 37.47 | 0.016 |
| Age Group | ||||||
| 15–19 | 1% | 3% | -0.131 | 1% | 1% | -0.029 |
| 20–24 | 7% | 12% | -0.152 | 7% | 7% | 0.007 |
| 25–29 | 16% | 20% | -0.108 | 16% | 15% | 0.019 |
| 30–34 | 18% | 20% | -0.055 | 18% | 19% | -0.018 |
| 35–39 | 17% | 15% | 0.040 | 16% | 17% | -0.015 |
| 40–44 | 16% | 11% | 0.141 | 15% | 15% | 0.006 |
| 45–49 | 11% | 8% | 0.112 | 11% | 11% | -0.005 |
| 50–54 | 8% | 6% | 0.094 | 8% | 8% | 0.003 |
| 55–59 | 3% | 3% | 0.036 | 3% | 3% | 0.050 |
| 60–64 | 2% | 2% | 0.012 | 2% | 2% | -0.020 |
| 65+ | 1% | 1% | -0.009 | 1% | 1% | 0.003 |
| CD4 Count (Mean) | 202.29 | 228.70 | -0.179 | 202.37 | 205.16 | -0.023 |
| sqrt(CD4 Count) (Mean) | 13.54 | 14.15 | -0.123 | 13.54 | 13.66 | -0.028 |
| CD4 Count Category | ||||||
| < 50 cell/uL | 8% | 10% | -0.071 | 8% | 7% | 0.031 |
| 50–199 cells/uL | 44% | 37% | 0.128 | 44% | 44% | -0.003 |
| 200–349 cells/uL | 41% | 39% | 0.047 | 41% | 41% | 0.005 |
| 350–499 cells/uL | 4% | 8% | -0.137 | 5% | 6% | -0.047 |
| ≥ 500 cells/uL | 3% | 6% | -0.163 | 3% | 2% | 0.007 |
| Weight (Mean) | 56.51 | 57.62 | -0.123 | 56.54 | 56.78 | -0.027 |
| Weight Category | ||||||
| 45–60 | 74% | 70% | 0.100 | 74% | 74% | 0.016 |
| >60 | 26% | 30% | -0.100 | 26% | 26% | -0.016 |
| CASG Eligible | ||||||
| No | 20% | 61% | -0.920 | 20% | 19% | 0.034 |
| Yes | 80% | 39% | 0.920 | 80% | 81% | -0.034 |
| Employment Status | ||||||
| Unemployed | 8% | 7% | 0.019 | 8% | 7% | 0.040 |
| Student | 3% | 4% | -0.076 | 3% | 3% | 0.003 |
| Work at home/housewife | 42% | 44% | -0.028 | 42% | 44% | -0.045 |
| Farmer | 25% | 17% | 0.190 | 25% | 24% | 0.032 |
| Employed | 23% | 28% | -0.126 | 23% | 23% | -0.005 |
Note: Estimates average across 100 imputed datasets.
* The number of matched CASG and non-CASG ranged from 6,609 to 6,662, with an average of 6,648.